Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman — Liège

Public research footprint of Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Neoplasms · Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Non-Segmental Vitiligo (NSV)

Recently updated registry entries

NCT07533019 — A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo (Recruiting)
NCT07222332 — A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults… (Recruiting)
NCT06937099 — Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.